Event:	Central Nervous System Disease Conference
Date/Time:	Thursday, November 17, 2016
Location:	Maxim Group LLC, New York, NY

Related Posts

Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73 (blarcamesine) in People with Parkinson’s Disease
January 11, 2021

Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect Conference
January 6, 2021

Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates
December 28, 2020

Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
December 22, 2020